Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 210 | 628 | 1,540 | 1,478 | 1,206 |
| Cost of Goods | 184 | 1,253 | 4,300 | 2,267 | 2,265 |
| Gross Profit | 26 | -625 | -2,760 | -789 | -1,059 |
| Operating Expenses | 16,142 | 12,555 | -13,530 | 9,170 | 8,674 |
| Operating Income | -15,932 | -12,927 | 11,070 | -9,692 | -9,468 |
| Interest Expense | 1,194 | 958 | 1,565 | 1,532 | 1,471 |
| Other Income | 14 | 14,565 | -24,768 | -366 | -88 |
| Pre-tax Income | -17,112 | 680 | -15,263 | -11,590 | -11,027 |
| Net Income Continuous | -17,112 | 680 | -15,263 | -11,590 | -11,027 |
| Net Income | $-17,112 | $680 | $-15,263 | $-11,590 | $-11,027 |
| EPS Basic Total Ops | -39.50 | 1.50 | -35.50 | -27.50 | -26.00 |
| EPS Basic Continuous Ops | -39.57 | 1.57 | -35.56 | -27.31 | -26.14 |
| EPS Diluted Total Ops | -39.50 | 0.00 | -35.50 | -27.50 | -26.00 |
| EPS Diluted Continuous Ops | -39.57 | 0.12 | -35.56 | -27.31 | -26.14 |
| EBITDA(a) | $-1,856 | $-1,892 | $18,004 | $-3,110 | $-3,340 |